Maximize Efficiency and Drive Business Results

NKF and Meitheal Announce Dr. Jiali Luo as General Manager of New Biopharmaceutical Business. Happenings. NKF and Meitheal Announce Dr. Jiali Luo as ... Xentria landed a nearly $700 million licensing agreement with Meitheal Pharmaceuticals, a local drugmaker that spun out Xentria in 2020. Meitheal Pharmaceuticals, Chicago, IL, Generics. Novian Health, Chicago, IL ... Xentria, Chicago, IL, Biologics & Biosimilars, Monoclonal Antibody. Xeris ... Xentria Secures Landmark Agreement with NYU for Cardiovascular Therapy Development ... The Growing Crisis of Antimicrobial Resistance: Meitheal ... In a significant ... Xentria entered into an exclusive multi-year licensing agreement with Meitheal Pharmaceuticals to commercialize its lead candidate and novel ... ... Meitheal Pharmaceuticals, Inc.（以下简称“Meitheal”“被许可方”）拟与Xentria签署《许可、开发与商业化协议》（以下简称《许可协议》），Xentria授予 ... Popular SearchesXentria IncXentria Corporation LtdXentria Group of Companies LtdXentria ... Xentria and Meitheal Pharmaceuticals Announce Exclusive Licensing ... Tom Shea is the founding President of Xentria and the founding CEO of Meitheal Pharmaceutical, Inc. In a deal valued in excess of $600 million, Meitheal will obtain sole rights to market the biologic in North America, with Xentria continuing to ... Xentria is a drug development company with ... In 2023, XTMAB-16 was exclusively licensed by Meitheal ... Founding President Tom Shea, MBA is also ...